The positive rate of 68Ga-PSMA-11 PET/CT was 53.6% in patients with PCa whose serum PSA level decreased after radical treatment, and it was related to the clinical stage of biochemical recurrence [153]. The gene discussed is FOLH1; the disease is posterior cortical atrophy.